Showing 61 - 70 of 33,460
We estimate and decompose family income-related inequality in child health in the US and analyze its dynamics using the income-related health mobility index recently introduced by Allanson et al., 2010. Data come from the 1997, 2002, and 2007 waves of the Child Development Supplement (CDS) of...
Persistent link: https://www.econbiz.de/10013120563
Persistent link: https://www.econbiz.de/10013089220
Objective: To estimate the cost-effectiveness for Colombia of four asymptomatic-bacteriuria (ABU) screening alternatives in pregnant women: a) urine culture, b) Gram stain, c) urianalysis and d) urianalysis followed by urine culture after a positive result.Methods: Two decision trees were built...
Persistent link: https://www.econbiz.de/10013089221
Objective: To estimate the cost-effectiveness of the etiological approach with rapid tests at the site of care compared to the syndromic diagnosis in non-pregnant women with symptoms of lower genital tract infection.Materials and Methods: A decision tree was built in TreeAge® to estimate the...
Persistent link: https://www.econbiz.de/10013089222
Objective: To estimate the cost-effectiveness of local vs. oral antibiotic in non-pregnant women with vaginal discharge suggestive of bacterial vaginosis.Methods: We compared four combinations of antibiotics for the first option and for the treatment of clinical failure: vaginal clindamycin and...
Persistent link: https://www.econbiz.de/10013089223
Persistent link: https://www.econbiz.de/10013089224
Objective: To assess the cost-effectiveness of risk stratification tests vs. not doing them in pediatric population with acute myeloid leukemia (AML).Methods: A decision tree model was built with life years gained as outcome, from the perspective of the health system, and including all direct...
Persistent link: https://www.econbiz.de/10013089225
Methods: A decision tree model was built with life years gained as outcome, from the perspective of the health system, and including all direct costs. Pharmaceutical prices were obtained from the System of Information of Medicaments SISMED (2008), and the value of procedures was calculated from...
Persistent link: https://www.econbiz.de/10013089226
Objetive: To assess the cost effectiveness of unrelated stem cell transplantation versus consolidation chemotherapy in pediatric population with high-risk acute myeloid leukemia (AML).Methods: A decision tree model was built with life years gained as outcome, from the perspective of the health...
Persistent link: https://www.econbiz.de/10013089227
Objective: To estimate the cost-effectiveness of 18FDG-PET/CT compared to CT followed by 18FDG-PET/CT as a confirmatory test for a positive case at the end of treatment in patients less than 18 years with Hodgkin lymphoma.Materials and Methods: A decision tree in TreeAge® was built to compare...
Persistent link: https://www.econbiz.de/10013089228